Evidence map›Paper›PMID 40225445›Full record

ReviewCureus2025

Physiological Mechanisms and Therapeutic Applications of Microneedling: A Narrative Review.

Lily Tehrani, Michelle Tashjian, Harvey N Mayrovitz

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lily TehraniDr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, USA.
Michelle TashjianDr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, USA.
Harvey N MayrovitzDr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Davie, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microneedling (MN), also known as percutaneous collagen induction therapy, is a minimally invasive dermatologic procedure that stimulates the skin's intrinsic wound repair cascade by creating controlled micro-injuries to the epidermis and dermis using multiple small-sized needles. This review aims to document and discuss the skin's physiological mechanisms activated through the MN process and its therapeutic applications and, where possible, to describe the impacts on changes in the skin's biophysical properties. Three databases, namely, PubMed, Web of Science, and Embase, were searched for relevant peer-reviewed articles published in English between 1990 and 2024. After eliminating duplicate and irrelevant articles, 70 studies were included in this review. The main physiological mechanisms associated with the MN process were collagen and elastin production, angiogenesis, transient increases in skin permeability, and improved epidermal barrier function post-treatment. Therapeutic applications targeted cosmetic improvements, scar healing, and drug delivery. As the wound repair process is initiated, fibroblasts migrate to the wounded area to initiate collagen and elastin production, contributing to the improved firmness and elasticity of the healed epidermis. The micropores created by MN increase skin permeability, allowing hydrophilic water-soluble molecules to transfer across the skin to enhance transdermal drug delivery and absorption. Multiple growth factors are secreted by monocytes upon injury and contribute to collagen production, epithelization, and angiogenesis, which increase epidermal thickness and epidermal barrier enhancement found post-procedure. Additionally, TGFM-1, a cross-linker of the protein filaggrin, and ki67, a marker of cell proliferation, are upregulated following the controlled tissue injury. These upregulated biomarkers contribute to the increase in filaggrin and the improvement of skin barrier function. Ceramides, which help retain moisture and prevent transepidermal water loss, are also increased when MN is combined with a solution containing human adipose tissue stem cell-derived exosomes. The cosmetic applications included improvements in skin texture, wrinkles, and scarring. As a minimally invasive procedure, MN is reported to have a low risk of post-procedural hyperpigmentation, scarring, or other adverse effects.

Indexed as

angiogenesisceramidescollagendrug deliveryelastinfilaggrinmicroneedlingpercutaneous collagen inductiontransepidermal water loss

Identifiers

PMID40225445
PMCPMC11993440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.